Screening your workforce for coronavirus is vital. Recent studies suggest that a high percentage of patients show no or few clinical symptoms. This means that one of your employees could be attending work as usual and unwittingly infect other members of your workforce.
Thankfully, help is at hand with the AlphaBiolabs IgM-IgG Combined Antibody Rapid Test from AlphaBiolabs. This accurate test is similar to the type that was widely used in China by the Chinese CDC to help identify COVID-19 infections. It works by detecting both early and late marker IgG/IgM antibodies in human finger-prick blood samples.
The easy-to-administer test can be performed by the individual themself at home or company nurse or Occupational Health personnel.
How does the coronavirus (COVID-19) screening test work?
Screening for COVID-19 IgM and IgG antibodies is an effective method for the rapid diagnosis of COVID-19 infection. It can also provide information on the stage of infection.
Immunoglobulin M (IgM) is the body’s largest antibody. As the figure shows, it is also the first antibody to appear in response to an initial exposure to an antigen (a toxin or other foreign substance), which induces an immune response in the body. IgM provides the first line of defence during viral infections, followed by the generation of adaptive, high affinity Immunoglobulin G (IgG) responses for long-term immunity and immunological memory.
This means that:
- Detection of IgM antibodies tends to indicate a recent exposure to COVID-19.
- Detection of IgG antibodies indicates a later stage of infection.
The results are displayed in the detection window of the testing device within 15 minutes.
The AlphaBiolabs IgM-IgG Combined Antibody Rapid Test is now available for £125 + VAT online. For further information, please visit our webpage. Alternatively, please contact our Customer Services team on 0333 600 1300, or email firstname.lastname@example.org